Zoetis Q3 FY25: where the revenue came from and where it went
The whole income statement of Zoetis for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2025
- Reported
- Nov 4, 2025
Revenue$2.40B
+1% year over year
Gross profit$1.72B
72% margin
Operating profit$0.87B
36% margin
Net profit$0.72B
30% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 2.40 | 100% | +1% |
| Parasiticides | 0.56 | 23% | |
| Vaccines | 0.50 | 21% | |
| Dermatology | 0.47 | 20% | |
| Other revenue | 0.27 | 11% | |
| Pain sedation | 0.20 | 8% | |
| Other pharmaceuticals | 0.18 | 7% | |
| Swine | 0.11 | 5% | |
| Animal health diagnostics | 0.11 | 5% | |
| Cost of revenue | −0.68 | 28% | |
| Gross profit | 1.72 | 72% margin | +1pp |
| SG&A | −0.58 | 24% | +0pp |
| Other | −0.26 | 11% | +0pp |
| Operating profit | 0.87 | 36% margin | +0pp |
| Other income, net | 0.01 | ||
| Tax | −0.17 | ||
| Net profit | 0.72 | 30% margin | +1pp |
98 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest